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Background/aim: Hypertension is a known risk factor for developing atrial fibrillation. However, there is limited data to investigate
the association between morning blood pressure surge (MBPS) and paroxysmal atrial fibrillation (PAF). We conducted the present
study to determine whether there is a relationship between asymptomatic PAF and MBPS and whether MBPS may be a predictor of
asymptomatic PAF episodes.
Materials and methods: This prospective study comprised 264 adult patients who were newly diagnosed with essential hypertension
or were previously diagnosed but not receiving regular antihypertensive therapy. We evaluated the patients in 2 groups according to
their 24-h electrocardiography monitoring results: group 1 included patients who exhibited PAF (n = 32, 23 females/9 males; mean age
60.2 ± 7.4 years) and group 2 included patients with no signs of PAF as a control group (n = 232, 134 females/98 males; mean age 56.9
± 9.4 years). We calculated the MBPS as the difference between mean systolic blood pressure (SBP) in the 2 h after getting up and the
minimum nocturnal SBP.
Results: MBPS values were significantly higher in group 1 than in group 2 (35.3 ± 7.0 vs. 22.0 ± 6.7, p < 0.001). MBPS was positively
associated with left atrial diameter (LAD) (r = 0.441, p < 0.001), left ventricle mass index (LVMI) (r = 0.235, p < 0.001), the ratio of early
(E) peak of mitral inflow velocity to early (Em) diastolic mitral annular velocity (E / Em) (r = 0.239, p < 0.001), 24-h mean (r = 0.270, p <
0.001) and daytime SBP (r = 0.291, p < 0.001). We determined a cut-off value for MBPS as 28.6 for predicting PAF episodes development
and identified LAD and MBPS as independent risk factors for PAF.
Conclusion: Patients who had larger MBPS were observed to have higher PAF incidence. MBPS values may be sensitive in predicting
asymptomatic episodes of paroxysmal atrial fibrillation.
Key words: Atrial fibrillation, blood pressure monitoring, blood pressure, hypertension, ambulatory electrocardiography monitoring

1. Introduction
Cardiovascular parameters like blood pressure (BP), heart
rate, vascular endothelial function, and coronary tone
change with circadian rhythm [1]. Fox and Mulcahy [2]
showed that the circadian rhythms of BP and heart rate were
virtually identical in normotensive subjects; both fell and
remained relatively low throughout the night and then rose
sharply in the early morning hours to reach a peak during
the morning. In terms of blood pressure, this phenomenon
is referred to as the morning blood pressure surge (MBPS).
There is growing interest in the role of the MBPS in various
cardiovascular and cerebrovascular diseases because most
cardiovascular events, including myocardial infarction,
sudden death, and stroke, occur in the morning hours
[3]. Many mechanisms have been proposed to explain the

higher incidence of cardiovascular events in the morning,
including BP elevation, sympathetic activation, plasma
catecholamine and cortisol levels, platelet aggregation,
and hypercoagulability [4]. However, among these factors,
the MBPS is believed to be most strongly associated with
cardiovascular events [5]. Numerous factors can increase
MBPS, such as hypertension (HT), alcohol usage, physical
and psychological stress, abnormal glucose metabolism,
smoking, salt intake, temperature, autonomic dysfunction,
and aging [6]. A mild MBPS is physiologically necessary
to supply the blood flow required in response to
increased activity. However, excessive MBPS is associated
with cardiovascular events like myocardial infarction,
arrhythmias, sudden cardiac death, and stroke [7]. Blood
pressure is not a constant variable; instead, it shows
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significant spontaneous oscillations over short and longterm periods [8]. It is called blood pressure variability (BPV).
There are many factors that affect BPV such as sympathetic
activity, baroreflex mechanism and neurohumoral factors.
Grassi et al. speculated that sympathetic activation is a
major mechanism for determining the BPV [9]. The factors
affecting BPV mentioned above can also cause cardiac
arrhythmias. Recent studies show that excessive BPV
modestly increases the risk of atrial fibrillation (AF) [10].
Furthermore, Kamioka et al. speculated that both systolic
and diastolic BPV were associated with AF recurrence
in AF patients with HT [11]. Excessive BPV is known to
be associated with an increased risk of AF through the
LV diastolic dysfunction and structural and functional
remodeling of the heart following electrophysiological
changes of the left atrium. Embolic events such as stroke,
congestive heart failure, and increased morbidity and
mortality due to AF render this condition a major clinical
problem. Atrial fibrillation is not perceived at all by the
patient and, in this case, is called asymptomatic or silent AF
[12]. Therefore, the reported prevalence of AF is believed to
be lower than the actual rate [13].
The mechanisms underlying MBPS are variable and
highly complex. The mechanisms by which increased
MBPS may increase the risk of AF are not clear either. In
addition, MBPS may cause intravascular shear force and
vasospasm, increasing the blood viscosity, and promoting
the secretion of inflammatory factors [14]. The potential
mechanisms related MBPS we mentioned above are
also associated with AF. Harada et al. speculated that
inflammation is associated with endothelial dysfunction,
platelet activation, and coagulation cascade activation.
Therefore, inflammation may contribute to the occurrence
of AF and its thromboembolic complications [15]. Other
conditions related to both AF and MBPS are increased
arterial stiffness in large arteries, renin angiotensin
aldosterone system (RAAS) overactivation, autonomic
dysfunction, and decreased baroreflex sensitivity [7]. Our
study was not designed to answer the question of which
occurs first, the BP surge (even when within normal limits)
or the sympathetic and RAAS activation, although the
latter would be a more logical explanation. Considering
the similar pathogenesis of MBPS and AF and due to the
high morbidity and mortality of AF, we conducted the
present study to determine whether there is a relationship
between asymptomatic paroxysmal atrial fibrillation
(PAF) and MBPS and whether MBPS may be a predictor
of asymptomatic PAF episodes.
2. Materials and methods
We designed this study as a prospective case-control study.
The study protocol was approved by Manisa Celal Bayar
University ethics committee, and the study was conducted

in accordance with the tenets of the Declaration of Helsinki.
Written informed consent was obtained from all participants
before the study. This study included 264 adult patients with
essential HT who were newly diagnosed or were previously
diagnosed but had not received regular antihypertensive
treatment in the last 6 months. We selected the participants
by random sampling of patients who presented to the
cardiology outpatient clinics of our hospital and recorded
the patients’ personal information and medical history.
Body mass index (BMI; weight [kg] / height [m]2) was
calculated for each patient. In all subjects, standard supine
12-lead resting electrocardiographies (ECG) were obtained
at baseline. We excluded the patients with severe chronic
kidney disease, severe heart failure, cancer, suspected
secondary hypertension, alcohol consumption, and
excessive physical activity in the morning from the study.
Patients who were using ACE inhibitors, beta-blockers,
angiotensin receptor antagonists, digoxin, nitrates, and
diuretics at the time of enrollment were excluded with a
concern of an effect on blood pressure measurements and
chronotropic effects. In addition, patients with known AF,
self-reported pulse irregularity, and palpitations or syncope
history in the previous year were excluded from analysis.
In all subjects, laboratory samples were obtained after a
12-h overnight fast using standardized methods. After the
patients rested for 5 to 10 min in sitting position, 5 blood
pressure measurements were obtained (1 per minute)
using an Omron M3 oscillometric monitor (Omron
Healthcare, Kyoto, Japan) and average of all measurements
were accepted as office blood pressure. HT was defined
according to the criteria specified in the 2018 European
Society of HT/European Society of Cardiology Guidelines
for the management of arterial HT: systolic BP (SBP) >
140 mmHg and/or diastolic BP (DBP) > 90 mmHg [16].
BP and cardiac rhythm were monitored simultaneously
for 24 h using validated devices (Risingmed RM-ABPM1
[Beijing, China] and Holter monitor). BP was measured
at 15-min intervals during the day and 30-min intervals at
night. For this study, daytime ambulatory blood pressure
(ABP) was calculated as the average BP from 6 AM to 8
PM, and nocturnal BP was calculated as the average BP
between 8 PM to 6 AM. Mean 24-h daytime and nighttime
systolic blood pressure (SBP) and diastolic blood pressure
(DBP) values were calculated. MBPS was calculated using
the formula: MBPS = Mean SBP in the first 2 h after getting
up − minimum nighttime SBP.
We stratified patients in 2 groups according to the
results of 24-h ambulatory ECG monitoring. Patients who
exhibited PAF on Holter ECG were included in group 1
and those with no signs of PAF on Holter ECG in group 2.
An episode of PAF was defined as one lasting longer than
30 s beginning and/or ending during the 24-h recording
with continuous irregular R-R intervals and randomly
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oscillating baseline with absence of P waves. The time of
the occurrence of the PAF episode was categorized into
4-h intervals based on a 24 hour clock.
Two-dimensional transthoracic echocardiographic
examination was performed (General Electric Vivid PRO
7, New York, USA) from standard parasternal long- and
short-axis and apical 2-, 3-, and 4-chamber views. Left
ventricle (LV) systolic and diastolic diameters, left atrial
diameter (LAD), aortic diameter, LV mass index (LVMI)
and LV ejection fraction (LVEF) (Simpson’s method)
[17] were measured by 2-dimensional transthoracic
echocardiography. LVMI was calculated from Devereux
formula [18] indexed to body surface area. The early (E)
and late (A) peak of mitral inflow velocities and early (Em)
and late (Am) diastolic mitral annular velocities were
obtained from the apical 2- and 4-chamber views.
2.1. Statistical analysis
All statistical analyses were performed with SPSS
version 24.0 (SPSS Inc, Chicago, USA). We expressed
categorical data as an absolute number and percentage,
and continuous data as mean ± standard deviation (SD).
The power analysis for the logistic regression analysis in
this study was conducted according to Aberson using
the `pwr2ppl` package in R programming language. The
analysis was conducted to get a sense of the required
sample sizes for different magnitudes of effect size and
event ratio probabilities [19]. The normality test was
performed by using the Kolmogorov–Smirnov test.
Differences between the categorical data were assessed
using the chi-squared test. Independent t-test was
used to compare the groups. The Pearson correlation
coefficient (r) was used to examine correlations between
the variables. Partial correlation was conducted to control
the effect of the confounding factors including BMI and
age. The predictors of PAF estimation were determined via
regression analysis. Factors with statistical significance (p
< 0.05) were included in the stepwise logistic regression
analysis to determine the independent predictors of
PAF episodes. The pairwise correlations between the
variables MBPS, daytime, nighttime and 24 h BP averages
were almost all significant and most of them were quite
strong. Therefore, a variable selection procedure had to be
implemented, all these candidate variables were fed into
forward selection so a forward selection procedure was
applied, and receiver operating characteristic (ROC) curve
was constructed to detect the cut level of MBPS, where
at this level, there are the best sensitivity and specificity
cutoff values of the variables for the presence of the PAF.
Statistical significance was defined as p < 0.05.
3. Results
The study group comprised 264 patients with a female
predominance (157 [59.5%] women, 107 [40.5%] men)
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and mean age of 57.3 ± 9.2 (range: 31–77) years. According
to the results of 24-h ECG monitoring, 32 patients (12.2%)
were in group 1 (PAF+, 23 females/9 males; mean age:
60.2 ± 7.4 years) and 232 patients (87.8%) were in group
2 (control, 134 females/98 males; mean age: 56.9 ± 9.4
years). No significant differences were observed between
the groups in terms of age (p = 0.055), BMI (p = 0.084),
sex distribution (p = 0.127), and smoking (p = 0.872).
Mean MBPS was significantly higher in group 1 compared
to that of group 2 (p < 0.001). Twenty-four hour mean (p
= 0.001) and daytime SBP (p = 0.002) were also higher
among the group 1 patients relative to group 2. There were
no significant differences in comorbid diseases including
diabetes mellitus (DM), renal failure (CKD), chronic
ischemic artery disease (CIAD), and chronic obstructive
pulmonary disease (COPD) between the groups. The
dipper status and surge type MBP pattern were prominent
in group 1. The clinical characteristics of the patients and
ambulatory blood pressure monitoring (ABPM) findings
are summarized in Table 1.
Comparison of echocardiographic findings in the
study groups is shown in Table 2. Group 1 had significantly
higher LAD (p < 0.001), LVMI (p < 0.001), E/Em (p <
0.001) ratio, E/A ratio (p = 0.004), posterior wall (PW)
thickness (p = 0.007), and interventricular septum (IVS)
thickness (p = 0.015) compared to group 2. Furthermore,
LVEF was similar between the groups. There were no
significant differences in other parameters between the
study groups. Furthermore, there were no significant
differences in terms of laboratory parameters between the
study groups (Table 5)
There was positive correlation between MBPS and 24-h
mean SBP (r = 0.270, p < 0.001), daytime SBP (r = 0.291,
p < 0.001), LAD (r = 0.440, p < 0.001), LVMI (r = 0.235,
p < 0.001), E/Em (r = 0.239, p < 0.001), IVS thickness (r
= 0.188, p = 0.002), and posterior wall (PW) thickness (r
= 0.221, p < 0.001). MBPS was not significantly correlated
with any of the other parameters. In addition, when
controlled for possible confounders (age and BMI), the
significant correlation of parameters with MBPS remained
statistically significant except for E/A ratio (Table 3).
ROC curve analysis was performed to obtain a cutoff value for MBPS to predict the development of PAF
episodes as shown in Figure 1. The cut-off value for
MBPS was determined as 28.6 and the area under the
curve was calculated. At this cut-off value, the sensitivity
for predicting PAF episodes development was 81.3% and
specificity was 84.9%.
Binary logistic regression analysis was performed to
assess the utility of the model generated using the patients’
MBPS values. The accurate estimation rate of the model
was 93.9%. We also performed logistic regression analysis
using MBPS, LAD, E/Em, smoking, sex, BMI, and age as
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Table 1. The comparison of baseline clinical and demographic characteristics and blood pressure values in patients with PAF and control
groups.
Group 1 (PAF+)
(n = 32, mmHg)

Group 2 (PAF-)
(n = 232, mmHg)

p-value*

Sex (female/male)*

23/9

134/98

0.127

Age (years)

60.2 ± 7.4

56.9 ± 9.4

0.055

Smoking (n,%)*

8 (25)

55 (23.7)

0.872

BMI (kg/m2)#

26.7 ± 2.4

25.8 ± 2.9

0.084

DM (n,%)*

6 (18.8)

34(14.7)

0.545

CIAD (n,%)*

3 (9.4)

24(10.3)

0.865

COPD (n,%)*

2 (6.3)

13(5.6)

0.882

2 (6.3)

7(3.0)

0.345

134.3 ± 22.7

133.2 ± 14.7

0.720

Office DBP, mmHg

81.8 ± 10.7

81.8 ± 9.4

0.981

24-h SBP, mmHg

145.1 ± 21.0

136.4 ± 13.2

0.001

24-h DBP, mmHg

79.6 ± 13.2

78.9 ± 10.0

0.706

Daytime SBP, mmHg#

147.2 ± 20.5

138.6 ± 13.7

0.002

Daytime DBP, mmHg#

81.4 ± 13.2

81.0 ± 11.0

0.843

Nighttime SBP, mmHg#

129.4 ± 25.7

126.9 ± 18.4

0.502

Nighttime DBP, mmHg

73.8 ± 15.9

73.9 ± 11.0

0.964

35.3 ± 7.0

22.0 ± 6.7

<0.001

#

CKD (n,%)*
Office SBP, mmHg

#
#

#
#

MBPS, mmHg

#

#

0.004

MBP pattern, %*
Nocturnal type

31.3

58.2

Surge type

68.8

41.8

Dipper

62.5

37.1

Nondipper

18.8

46.6

Extreme dipper

12.5

11.6

Riser

6.3

4.7

Dipping status, %*
0.021

*Chi-squared test; # Independent t-test; BMI: Body mass index, PAF: Paroxysmal atrial fibrillation; SBP: Systolic blood pressure; DBP:
Diastolic blood pressure; MBPS: Morning blood pressure surge; DM: Diabetes mellitus; CIAD: Chronic ischemic artery disease; COPD:
Chronic obstructive pulmonary disease; CKD: Chronic kidney disease.
Bold values indicate statistical significance (p < 0.05).

independent variables to predict the development of PAF
episodes. The relationship between these independent
variables and PAF episodes development were examined.
Left atrial diameter and MBPS were found to independently
increase the risk of development of PAF. The odds of
developing PAF episodes increased by 20% with each
additional 1 mm increase in LAD and 17% with each 1
mmHg increase in MBPS (Table 4).

A total of 52 episodes were obtained from 24-h ECG
Holter of 32 patients with PAF. The time intervals for
occurrence of PAF episodes were as follows: 6 (11.5%)
between 2 AM and 6 AM, 13 (26.9%) between 6 AM and
10 AM, 9 (17.3%) between 10 AM and 2 PM, 13 (23%)
between 2 PM and 6 PM, 7 (13.4%) between 6 PM and 10
PM, and 4 (7.6%) between 10 PM and 2 AM as shown in
Figure 2.
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Table 2. The comparison of echocardiographic findings in patients with PAF and control groups.
Group 1 (PAF+)
(n = 32)

Group 2 (PAF-)
(n = 232)

p-value*

LVEF#

60.6 ± 3.8

60.2 ± 3.4

0.554

E#

103.1 ± 26.6

92.7 ± 24.7

0.029

A

75.4 ± 25.2

79.7 ± 20.3

0.279

6.7 ± 2.1

8.1 ± 2.0

<0.001

E/Em

16.2 ± 4.7

11.8 ± 3.6

<0.001

E/A#

1.5 ± 0.8

1.2 ± 0.5

0.004

#

Em#
#

114.4 ± 22.6

102.2 ± 16.6

<0.001

#

IVS, mm

11.8 ± 1.6

11.2 ± 1.3

0.015

PW, mm#

11.6 ± 1.6

10.8 ± 1.5

0.007

43.0 ± 4.5

31.8 ± 6.7

<0.001

LVMI

#

LAD, mm

#

PAF: Paroxysmal atrial fibrillation; NSAF: Nonsustained atrial fibrillation; LAD: Left atrial diameter; LVEF: Left
ventricular ejection fraction; E/Em: Ratio of early (E) peak of mitral inflow velocity to early (Em) diastolic mitral
annular velocity; E/A: Ratio of early (E) to late (A) peak of mitral inflow velocity; LVMI: Left ventricular mass index;
IVS: Interventricular septum thickness; PW: Posterior wall thickness.Bold values indicate statistical significance (p <
0.05).
# Independent t-test.

Table 3. Pearson correlation analyses between morning blood pressure surge and age,
body mass index, blood pressure values, and echocardiographic findings.

Independent variables
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MBPS
(adjusted for age/BMI)

MBPS
r coefficient

p-value

Age

0.133

0.030

r
p-value
coefficient
–––
–––

BMI

0.109

0.076

–––

LAD

0.441

<0.001

0.425 <0.001

Office SBP

0.028

0.651

–0.021 0.732

Office DBP

–0.046

0.461

–0.082 0.186

24-h SBP

0.270

<0.001

0.242 <0.001

24-h DBP

0.023

0.707

0.011 0.863

Daytime SBP

0.291

<0.001

0.267 <0.001

Daytime DBP

0.053

0.391

0.044 0.478

Nighttime SBP

0.055

0.370

0.024 0.700

Nighttime DBP

–0.062

0.315

–0.078 0.206

LVEF

0.012

0.847

–0.018 0.767

E

0.036

0.564

0.033 0.598

A

–0.070

0.254

–0.069 0.268

Em

–0.182

0.003

–0.169 0.006

E/Em

0.239

<0.001

0.223 <0.001

–––

TAŞ et al. / Turk J Med Sci
Table 3. (Continued).
E/A

0.122

0.048

0.117 0.059

LVMI

0.235

<0.001

0.226 <0.001

IVS

0.188

0.002

0.161 0.009

PW

0.221

<0.001

0.202 0.001

MBPS: Morning blood pressure surge; BMI: Body mass index; LAD: Left atrial diameter;
SBP: Systolic blood pressure; DBP: Diastolic blood pressure; LVEF: Left ventricular
ejection fraction; E/Em: Ratio of early (E) peak of mitral inflow velocity to early (Em)
diastolic mitral annular velocity; E/A: Ratio of early (E) to late (A) peak of mitral inflow
velocity; LVMI: Left ventricular mass index IVS: Interventricular septum thickness; PW:
Posterior wall thickness.
Bold values indicate statistical significance (p < 0.05).

Figure 1. The receiver operating characteristic (ROC) curve for
morning blood pressure surge in the prediction of paroxysmal atrial
fibrillation; the optimal cut-off value of 28.6 had sensitivity of 81.3%
and specificity of 84.9%, area under receiver operating characteristic
curve: 0.909.

Figure 2. The number of episodes of runs of PAF in all PAF subjects
(n = 32).
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Table 4. Binary logistic analyses between PAF and age, BMI, MBPS, sex, E/Em ratio, and LAD.

Independent variables

Regression coefficient (B)

Wald (X2)

p-value

Dominance ratio

95% CI

Age

0.003

0.010

0.921

1.003

0.941–1.070

MBPS

0.162

15.822

<0.001

1.176

1.086–1.274

BMI

–0.061

0.380

0.538

0.941

0.775–1.142

LAD

0.184

13.345

<0.001

1.202

1.089–1.326

Sex (male)

–0.631

1.032

0.310

0.532

0.157–1.798

Smoking

0.345

0.272

0.602

1.411

0.387–5.147

E/Em

0.102

3.290

0.070

1.108

0.992–1.237

MBPS: Morning blood pressure surge; BMI: Body mass index; LAD: Left atrial diameter; E/Em: Ratio of early (E) peak of mitral inflow
velocity to early (Em) diastolic mitral annular velocity.
Bold values indicate statistical significance (p < 0.05).

4. Discussion
The aim of our study was to evaluate the relationship
between MBPS and asymptomatic occurrence of PAF
episodes. To the best of our knowledge, no study in the
literature has attempted to assess the relation between
MBPS and PAF up to now.
In our study, the PAF group exhibited significantly
higher MBPS, 24-h and daytime SBP, E/Em, LVMI, and
LAD, consistent with the literature [20-22]. In a general
population cohort consisting of 903 subjects, Perkiömäki
et al. determined that patients with AF had higher 24-h SBP
[23]. Tikhonoff and colleagues monitored 2776 patients
using ABP and ECG Holter devices and found that 24-h
SBP, daytime SBP, and nighttime SBP were significantly
higher in the AF group and systolic ABP was found as a
significant predictor of incident AF [24].
In the present study, we observed that the incidence
of PAF was significantly higher in patients with greater
MBPS values, especially over 28.6 mmHg. There are
numerous studies which investigate the predictors of AF
development [25, 26]. Domenech et al. reported that there
was a significant relationship between nighttime BP and
left atrial size and speculated that nighttime BP levels, but
not office BP levels, play the most important role in left
atrial remodeling and enlargement [27]. Perkiömäki et al.
speculated that nighttime SBP yields more information
for the long-term risk of AF compared with daytime SBP.
They examined 903 subjects with or without HT by using
ABP monitoring and followed them up for an average of
16.4 ± 3.6 years. In sum, they found that the nighttime
SBP is a significant independent contributor to the longterm risk of new-onset AF [23]. Although the design of
the Domenech’s and Perkiömäki’s studies does not fully
reflect that of our own, an important issue that needs to be
clarified emerges when evaluated together with the results
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of our study. Are all ABP findings, especially morning
BP, associated with left atrium enlargement and the
development of AF episodes? In our study, unlike other
ABPM findings, we observed that MBPS was correlated
with LAD and was linearly associated with PAF. Based on
the abovementioned evidence, it can also be speculated
that MBPS itself may induce structural and functional
alterations, mainly in the form of LA enlargement, such
that as MBPS increases, LA size also increases, which
seems to cause PAF, or as MBPS increases, neurohormonal
activity increases, which induces the pathways causing
PAF. However, it cannot be ruled out that increased
MBPS might be epiphenomena of other conditions
such as vascular aging and remodeling, arterial stiffness,
autonomic dysfunction, decreased baroreflex sensitivity,
and inflammatory processes that also increase the risk of
AF, so MBPS might simply be a marker of increased PAF
episodes from any cause. Longitudinal studies are needed
to clarify this issue further.
Vascular remodeling refers to any structural and
functional changes in the blood vessel wall. Rizzoni et al.
[28] speculated that vascular remodeling limit the capacity
to buffer the increase in MBP. Another vascular situation
related MBPS is vascular aging that trigger vascular
remodeling. It is associated with significant alterations in
the balance of vasoconstrictor and vasodilator production
and migration vascular smooth cells [29]. The predominant
hemodynamic effects of vascular aging are increased
arterial stiffness and wave reflection [30]. In their study,
Okada et al. showed that MBPS is associated with arterial
stiffness [31].
The arterial baroreflex buffers spontaneous
fluctuations in blood pressure through its actions on the
heart and vessels. Baroreflex sensitivity regulates the heart
rate and muscle nerve activity as a response to arterial
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Table 5. Comparison of laboratory findings in patients with and without PAF.
Group 1 (PAF+)
(n = 32)#

Group 2 (PAF-)
(n = 232)#

p-value

Glucose (mg/dL)

117.2 ± 43.1

113.1 ± 41.8

0.608

Urea (mg/dL)

39.3 ± 26.1

37.7 ± 18.2

0.659

Cre (mg/dL)

0.86 ± 0.14

0.85 ± 0.15

0.899

Na+ (mmol/L)

138.5 ± 2.9

137.5 ± 2.8

0.064

K (mmol/L)

4.38 ± 0.50

4.39 ± 0.37

0.930

Cl- (mmol/L)

100.0 ± 2.5

99.4 ± 2.4

0.214

Ca (mg/dL)

9.23 ± 0.79

9.35 ± 0.49

0.217

Mg (mg/dL)

2.01 ± 0.22

2.00 ± 0.20

0.738

Alb (mg/dL)

4.15 ± 0.49

4.20 ± 0.38

0.560

Total- C (mg/dL)

195.9 ± 36.2

193.0 ± 36.3

0.670

LDL- C (mg/dL)

129.0 ± 26.0

121.9 ± 31.4

0.225

HDL- C (mg/dL)

51.3 ± 17.4

50.7 ± 11.8

0.786

TG (mg/dL)

125.2 ± 53.5

149.4 ± 77.4

0.088

WBC (x10 /L)

8.8 ± 3.2

8.1 ± 3.0

0.211

PNL (x109/L)

5.9 ± 3.2

5.1 ± 2.8

0.152

LYM (x10 /L)

2.0 ± 0.8

2.1 ± 0.6

0.475

MONO (x109/L)

0.72 ± 0.43

0.70 ± 0.50

0.800

EOS(x10 /L)

0.14 ± 0.14

0.13 ± 0.12

0.685

RBC (x10 /L)

4.6 ± 0.5

4.7 ± 0.6

0.696

HB (g/dL)

13.1 ± 1.6

13.3 ± 1.4

0.487

HCT (%)

40.3 ± 4.8

40.9 ± 4.0

0.452

MCV (fL)

86.6 ± 4.4

86.7 ± 4.4

0.893

RDW-CV (%)

13.7 ± 1.8

13.6 ± 1.7

0.855

PLT (x109/L)

257.4 ± 82.3

264.3 ± 58.8

0.558

PCT (%)

0.26 ± 0.08

0.27 ± 0.05

0.262

MPV (fL)

10.4 ± 0.7

10.5 ± 0.8

0.629

PDW (%)

12.4 ± 2.1

12.5 ± 1.9

0.781

+

++

++

9

9

9

9

# Independent t-test, Cre: Creatinine, Alb: Albumin, C: Cholesterol, LDL: Low density lipoprotein, HDL:
High density lipoprotein, TG: Trigliserid, WBC: White blood cell, PNL: Polymorphonuclear leukocytes, LYM:
Lymphocyte, MONO: Monocyte, EOS: Eosinophil, RBC: Red blood cell, HB: Hemoglobin, HCT: Hematocrit,
MCV: Mean corpuscular volume, RDW: Red cell distribution width, PLT: Platelet, PCT: Plateletcrit, MPV:
Mean platelet volume, PDW: Platelet distribution width.

pressure changes. An impaired sensitivity of the vascular
sympathetic baroreflex or cardiac baroreflex could prevent
the buffering of morning BP increase, contributing to an
exaggerated MBPS. Okada et al. showed that sympathetic
BRS is reduced in elderly, hypertensive individuals with an
exaggerated systolic MSBP [31].
There are many and complex interconnected
mechanisms for developing arrhythmias in patients
with morning surge. Marfella et al. showed that MBPS

is associated with increased sympathetic activity and
prolonged QTc interval [32]. In addition, increase in
cardiac afterload is also associated with MBPS. Yee et al.
showed that increase in sympathetic activity and cardiac
afterload may cause considerable variability in ventricular
electrical activity by modifying repolarization time
[33]. These findings suggest that patients with MBPS
have considerable variability in electric excitation at the
myocardial level in response to sympathetic activity and
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thus are prone to developing arrhythmia. LA enlargement
and myocardial fibrosis are other important determinants
for developing arrhythmias. RAAS activation is closely
related to these functional and structural changes [34].
Therefore, it can be speculated that MBPS may be associated
with arrhythmias as a result of RAAS overactivation and
increased sympathetic outflow.
Furthermore, we found a significant relationship
between MBPS and 24-h BP and echocardiographic
parameters such as LAD, E/Em, and LVMI, we detected
positive correlations between MBPS and age, 24-h SBP,
daytime SBP, and echocardiographic parameters as
mentioned above. These findings support the findings of
Abdel-Khalik et al., who reported that MBPS was positively
correlated with LAD, 24-h daytime and nighttime SBP, and
IVS thickness [35] and those of Kuwajima et al. who found
a significant positive correlation between MBPS and LVMI
[36]. Likewise, Yilmaz et al. found a significant correlation
between MBPS and E/Em ratio as a marker of diastolic
dysfunction [37].
In addition to MBPS, we found a significant relationship
between PAF and LAD. Left atrial diameter is a known
predictor for AF development. Our principal finding was
that MBPS and LAD are significant predictors of PAF
episodes. These data underscore the need for a better
understanding of the complexity of AF determinants and
for improvement of AF prevention strategies related to the
specific modifiable risk factors.
The effect of circadian rhythm on PAF episodes
is another important issue. Discrepant findings have
been reported in the literature regarding the correlation
between supraventricular tachycardia (SVT) and circadian
rhythm. Two large studies examining the relationship
between paroxysmal SVT, PAF, and circadian rhythm
demonstrated no association between circadian rhythm
and PAF [38, 39]. Mitchell et al. and Viskin et al. suspected
that the distribution of episodic atrial fibrillation showed
a double peak, with a significant increase in the number
of episodes in the morning or afternoon and a second
rise in the evening [40, 41]. We found that PAF episodes
were more frequent in the early morning hours and
afternoon. This result might indicate that a close temporal
relationship between MBPS and PAF occurrence does not

exist and suggests that MBPS is not the direct cause of PAF.
The most important limitation of this study is the
small sample size. Secondly, the single LAD obtained by
2-dimensional-guided transthoracic echocardiogram
reflects the anteroposterior dimension and may not
accurately represent left atrial chamber dimensions in
all patients. Thirdly, the lack of statistical significance
of several suspected risk factors for PAF should not be
construed to mean that these factors are not possible risk
factors in individual patients. For example, age, smoking,
and BMI were not shown to be significant risk factors for
AF in our study, and this contradicts the literature data.
Fourthly, we could not perform comparative analyses
between the groups depending on the time at which PAF
episodes occurred because of the small number of PAF
episodes. In conclusion, there were significant differences
in MBPS, LAD, LVMI, and E/Em between patients with
and without PAF in our study. Specifically, patients who
had higher MBPS values were observed to have higher
PAF incidence. However, longitudinal studies are needed
to confirm our preliminary results, in particular to clarify
the role of MBPS in the development of PAF episodes
and determine the utility of these measurements in the
clinical setting. Therefore, the cut-off value of MBPS
identified in our study may assist in deciding the type and
timing of antihypertensive therapy with individualized
pharmacotherapy particularly aiming MBPS. Our
observations may also provide a new perspective for the
management of AF and also suggest that ABP monitoring
should become routine in the AF risk stratification of
patients with HT.
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